
Kromatid Secures $8M Series C Funding to Advance Genomic Structural Analysis Technology
KromaTiD, a pioneering force in next-generation genomic structural analysis, announced the successful close of its Series C funding round, raising a total of $8 million and surpassing its targeted capital goals. The most recent tranche of the round contributed $3.8…